King Khaled Eye Specialist Hospital
14
0
0
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
7.1%
1 terminated/withdrawn out of 14 trials
92.3%
+5.8% vs industry average
29%
4 trials in Phase 3/4
17%
2 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Methotrexate and Mycophenolate Mofetil for UVEITIS
Role: collaborator
Trial of Subretinal Injection of (rAAV2-VMD2-hMERTK)
Role: lead
Sensitivity of Hyomental Distance Ratio as a Single Predictor of Difficult Intubation in Obstetrics
Role: lead
Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema
Role: lead
Anesthesia for Pars Plana Vitrectomy (PPV) With Insulin Needle
Role: lead
Treatment of PED With AMT and Autologous Serum
Role: lead
Influence of Glidescope Assisted Endotracheal Intubation on Intraocular Presure
Role: lead
Effect of Usage of Electroencephalogram (EEG) Entropy on the Incidence of Postoperative Cognitive Dysfunction in Geriatric Patients
Role: lead
Efficacy of Subtenon's Block With Olive Tipped Cannula
Role: lead
Late Onset Postoperative Nausea and Vomiting
Role: lead
Phaco-ECP vs Phaco Alone in Primary Angle Closure
Role: lead
Short-pulse Subthreshold vs Infrared Micropulse for Diabetic Macular Edema
Role: collaborator
An Observational Study of the Use of Chloral Hydrate for Ophthalmic Procedures in Children
Role: collaborator
Evaluation of Airtraq in Pediatric
Role: lead
All 14 trials loaded